The billionaire plans to remain at the firm and focus on strategy and mentoring.

JPMorgan could become the new Apple credit-card issuer, but is seeking concessions from the tech company.

Positive results of a colon cancer study conducted by Exact Sciences prompt the CEO of competitor Guardant Health to publicly challenge his rival to a bet.

A victory for the Federal Trade Commission, set to conclude Tuesday, could pave the way for an Amazon buying spree.

The cloud pioneer hopes AI agents make a splash at its Dreamforce conference and rejuvenate growth prospects.

The Federal Reserve’s next interest-rate decision could be a fateful one for many consumers and in turn for debates about the health of the American spender.